Safety and feasibility of 120 min rapid infusion regimen of daratumumab in patients with multiple myeloma.
- Author:
Tian Hang WANG
1
;
Rui HAO
1
;
Bao Nan XU
1
;
Liang CHANG
1
;
Zhao Bao LIU
1
;
Jia Lin YAO
1
;
Wen WANG
1
;
Wen Jun XIE
1
;
Wen qiang YAN
1
;
Zhi Jian XIAO
1
;
Lu Gui QIU
1
;
Gang AN
1
Author Information
- Publication Type:Journal Article
- MeSH: Humans; Multiple Myeloma/drug therapy*; Feasibility Studies; Antibodies, Monoclonal/adverse effects*; Dexamethasone/therapeutic use*; Antineoplastic Combined Chemotherapy Protocols
- From: Chinese Journal of Hematology 2023;44(8):696-699
- CountryChina
- Language:Chinese
